MTWM
Masso Torrence Wealth Management’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
50,000
+15,000
| +43% | +$60K | 0.09% | 96 |
|
|
2025
Q1 | $111K | Buy |
35,000
+5,000
| +17% | +$15.9K | 0.06% | 95 |
|
|
2024
Q4 | $161K | Buy |
30,000
+20,000
| +200% | +$107K | 0.08% | 93 |
|
|
2024
Q3 | $52.8K | Hold |
10,000
| – | – | 0.03% | 90 |
|
|
2024
Q2 | $18.2K | Hold |
10,000
| – | – | 0.01% | 92 |
|
|
2024
Q1 | $17.8K | Hold |
10,000
| – | – | 0.01% | 91 |
|
|
2023
Q4 | $17.6K | Hold |
10,000
| – | – | 0.01% | 88 |
|
|
2023
Q3 | $14.6K | Buy |
+10,000
| New | +$14.6K | 0.01% | 82 |
|
|
2022
Q1 | – | Sell |
-2,731
| Closed | -$7K | – | 133 |
|
|
2021
Q4 | $7K | Buy |
+2,731
| New | +$7K | ﹤0.01% | 287 |
|